This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-allergic asthma
ASTHMA_NONALLERG
asthma: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditions
|
437607 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
4083 |
6. Filter based on genotype QC (FinnGen only) |
3637 |
Control definitions (FinnGen only)
- Control conditions
- not (L12_ATOPIC
or ALLERG_RHINITIS
or H7_ALLERGICCONJUNCTIVITIS
or FOOD_ALLERGY
or Z21_DESEN_ALLERGE
or POLLENALLERG
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Non-allergic asthma
based on the number of shared cases.
Similar with more cases:
- Non-allergic asthma (mode), excluding more controls
- Non-allergic asthma (mode)
- Asthma
- Asthma, excluding more controls
- Asthma, including avohilmo
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3637 | 2024 | 1613 |
| Unadjusted period prevalence (%) | 0.73 | 0.72 | 0.74 |
| Median age at first event (years) | 55.98 | 53.27 | 59.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3773
- Matched controls
- 37695
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R03BA01
ATC
beclometasone; inhalant
5.8
307.7
1127
2593
R03BA08
ATC
ciclesonide; inhalant
6.3
307.7
750
1429
R03AK08
ATC
formoterol and beclometasone; inhalant
9.1
307.7
520
649
R03BA02
ATC
budesonide; inhalant
6.7
307.7
1540
3523
J45
ICD-10 Finland
Asthma
6.2
307.7
884
1761
R03AK07
ATC
formoterol and budesonide; inhalant
4.9
307.7
1490
4454
R03BA05
ATC
fluticasone; inhalant
4.9
307.7
1329
3760
R03DC03
ATC
montelukast; oral
5.3
307.7
1210
3058
H02AB06
ATC
prednisolone; systemic
3.8
307.7
2441
12236
R03AC02
ATC
salbutamol; inhalant
12.7
307.7
3369
14958
R96
ICPC
Asthma
5.9
307.7
861
1795
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
23.4
307.7
2741
3846
R03BB04
ATC
tiotropium bromide; inhalant
5.3
307.7
808
1853
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.2
307.7
1085
2730
J45.1
ICD-10 Finland
Nonallergic asthma
+∞
307.7
3773
1027
R03AC03
ATC
terbutaline; inhalant
5.0
307.7
981
2471
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
7.0
275.0
448
709
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
188.5
647
1913
R06.0
ICD-10 Finland
Dyspnoea
2.8
180.6
1384
6551
R03AC13
ATC
formoterol; inhalant
5.6
180.5
361
693
XQ800
NOMESCO Finland
Prick test
4.9
175.1
416
928
R06.2
ICD-10 Finland
Wheezing
5.3
166.0
360
742
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.9
142.1
264
471
J45.9
ICD-10 Finland
Asthma, unspecified
2.7
130.7
895
3910
R03AC12
ATC
salmeterol; inhalant
4.8
120.1
284
627
R05
ICD-10 Finland
Cough
2.4
111.2
1037
5186
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.0
110.5
339
913
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
12.0
109.3
111
95
J46
ICD-10 Finland
Status asthmaticus
5.7
100.7
192
350
R03DA04
ATC
theophylline; systemic, rectal
4.0
98.7
298
792
SPAT1058
SPAT
PEF monitoring instruction
3.1
94.3
431
1497
XG474
NOMESCO Finland
Exhalation nntrogen oxide
5.9
93.9
173
305
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
6.6
89.9
147
230
J01AA02
ATC
doxycycline; systemic
2.2
89.0
2934
23054
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.8
85.6
276
767
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
82.4
858
4423
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.0
77.2
369
1310
J01FA06
ATC
roxithromycin; oral
1.9
74.8
1511
9815
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.2
73.4
204
509
R01AD09
ATC
mometasone; nasal
1.8
69.4
1667
11361
R02
ICPC
Shortness of breath/dyspnoea
2.3
67.8
606
2912
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.3
67.7
264
829
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
65.1
377
1480
H02AB04
ATC
methylprednisolone; systemic
2.3
64.4
576
2764
R03AK11
ATC
formoterol and fluticasone; inhalant
4.6
62.2
152
343
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.3
61.5
241
759
J01FA10
ATC
azithromycin; systemic
1.7
54.0
2135
16342
R01AD12
ATC
fluticasone furoate; nasal
1.8
53.2
1140
7366
J01FA09
ATC
clarithromycin; systemic
1.8
51.2
1146
7484
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.9
50.5
153
406
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.9
49.3
238
845
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
47.6
432
2072
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
46.3
890
5532
R01AD08
ATC
fluticasone; nasal
1.8
45.1
957
6115
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.9
45.1
224
808
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
7.7
44.1
62
82
J31.0
ICD-10 Finland
Chronic rhinitis
2.3
41.6
332
1505
SPAT1059
SPAT
Spirometry at the office
2.7
41.3
227
863
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.4
40.6
298
1302
R03BB01
ATC
ipratropium bromide; inhalant
3.1
40.4
171
563
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
40.1
880
5648
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
5.6
39.9
76
138
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
5.1
39.5
83
165
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
4.0
38.8
110
278
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
37.8
1717
13140
J20
ICD-10 Finland
Acute bronchitis
2.1
37.7
397
2009
H02AB07
ATC
prednisone; oral
2.0
36.9
470
2546
R03BC03
ATC
nedocromil; inhalant
2.5
36.7
250
1056
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
36.6
189
695
A02BC01
ATC
omeprazole; systemic
1.7
36.1
954
6407
R01AD58
ATC
fluticasone, combinations; nasal
1.7
35.4
829
5393
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.5
34.9
121
352
R05
ICPC
Cough
1.6
34.8
943
6363
SPAT1057
SPAT
Peak expiratory flow measurement
3.7
34.4
111
308
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
33.7
950
6467
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
4.9
33.5
73
150
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.8
33.3
177
661
G47.3
ICD-10 Finland
Sleep apnoea
1.7
33.1
796
5201
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
31.9
1887
15081
R03DC01
ATC
zafirlukast; oral
4.8
31.5
71
150
J01CA04
ATC
amoxicillin; systemic
1.6
31.1
3015
26711
A02BC02
ATC
pantoprazole; systemic
1.5
30.7
2370
19927
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
30.4
158
583
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
30.3
1784
14191
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.8
30.0
153
559
R06AX27
ATC
desloratadine; oral
1.6
29.5
893
6155
GX1C5, ,
SPAT
5.6
28.9
55
100
J01MA14
ATC
moxifloxacin; systemic
2.0
28.5
318
1639
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
28.4
866
5972
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.0
28.2
123
412
XG405
NOMESCO Finland
Education on PEF monitoring
4.3
27.9
72
170
J32.4
ICD-10 Finland
Chronic pansinusitis
4.1
26.6
74
185
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
5.6
25.8
49
89
A02BC05
ATC
esomeprazole; systemic
1.5
25.7
1323
10149
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
25.7
1322
10142
R01AD01
ATC
beclometasone; nasal
1.7
25.4
464
2797
ZYC01, ,
SPAT
1.8
25.0
432
2562
R06AE07
ATC
cetirizine; oral
1.4
24.6
1366
10611
R03BB07
ATC
umeclidinium bromide; inhalant
5.3
24.1
48
91
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.8
24.0
54
114
C07AB07
ATC
bisoprolol; oral
1.4
23.7
1610
12944
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
23.6
143
571
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
5.4
23.5
46
86
J01FA15
ATC
telithromycin; oral
1.9
23.5
323
1786
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
23.1
325
1811
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
23.0
246
1248
R04.2
ICD-10 Finland
Haemoptysis
2.6
22.8
135
533
N02AX02
ATC
tramadol; systemic, rectal
1.4
22.7
1408
11113
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
22.7
960
7051
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
3.0
22.7
101
343
J47
ICD-10 Finland
Bronchiectasis
3.3
22.3
83
253
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
7.7
21.6
30
39
A02BC03
ATC
lansoprazole; oral
1.5
21.6
906
6632
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
5.1
21.6
45
89
R95
ICPC
Chron obstructive pulmonary disease
2.6
21.5
124
483
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
21.1
207
1017
J96.1
ICD-10 Finland
Chronic respiratory failure
3.0
20.9
93
316
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
20.5
227
1166
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
20.3
868
6370
R01AD05
ATC
budesonide; nasal
2.0
20.2
214
1081
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.7
20.0
106
396
ZXA10
NOMESCO Finland
Bilateral
1.6
20.0
605
4128
ZXH06, ,
SPAT
2.1
19.8
195
959
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
3.3
19.5
73
224
J01DA01
ATC
[U] cefalexin
1.4
19.5
2025
17271
R03BC01
ATC
cromoglicic acid; inhalant
4.1
19.3
52
127
GX1E5, ,
SPAT
3.6
19.0
62
174
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
3.2
19.0
76
243
J33.8
ICD-10 Finland
Other polyp of sinus
3.1
18.6
77
251
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
18.5
920
6929
XG413
NOMESCO Finland
Spirometry with oscillometry
7.9
18.3
25
32
N02BE01
ATC
paracetamol; systemic, rectal
1.5
18.2
3143
29005
WZC30, ,
SPAT
1.8
18.1
310
1830
WZC00, ,
SPAT
1.6
18.1
535
3627
Z3231
NOMESCO Finland
Registered nurse
1.4
18.0
899
6766
C03CA01
ATC
furosemide; systemic
1.4
17.8
964
7361
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
5.2
17.6
36
70
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
6.2
17.6
30
49
A01AB09
ATC
miconazole; local oral
1.8
17.5
272
1560
R05FB02
ATC
cough suppressants and expectorants; systemic
1.4
17.5
1154
9107
GD1AA, ,
SPAT
1.5
17.2
518
3523
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
16.6
911
6961
J43.9
ICD-10 Finland
Emphysema, unspecified
3.1
16.4
66
212
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
16.1
693
5066
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
16.0
571
4024
DHB20
NOMESCO Finland
Polypectomy of internal nose
3.3
15.9
60
185
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.3
15.9
115
499
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
15.7
1391
11448
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
4.7
15.4
35
75
R01AD11
ATC
triamcinolone; nasal
1.8
15.3
247
1432
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.8
15.1
76
277
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
15.0
1386
11453
ZXH09, ,
SPAT
2.6
14.9
88
348
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.4
14.9
102
433
J01DB01
ATC
cefalexin; oral
1.4
14.6
2842
26044
N03AX12
ATC
[U] gabapentin; oral
1.5
14.3
487
3393
OAB42, ,
SPAT
1.5
14.3
455
3127
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.8
14.0
208
1178
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
13.9
242
1435
R74
ICPC
Upper respiratory infection acute
1.3
13.6
1073
8638
R03CC02
ATC
salbutamol; systemic
1.8
13.4
210
1209
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.6
13.3
42
116
UGC02
NOMESCO Finland
Rigid bronchoscopy
5.3
13.2
26
49
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
13.1
1176
9635
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.6
12.9
71
272
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
2.9
12.8
59
206
SPAT1325
SPAT
Vaccination
1.3
12.7
1069
8666
N07BA03
ATC
varenicline; oral
1.9
12.7
147
768
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
12.5
967
7748
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
12.3
1161
9555
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.6
12.3
39
108
J98.6
ICD-10 Finland
Disorders of diaphragm
5.8
12.2
22
38
R03BA07
ATC
mometasone; inhalant
3.9
12.2
35
90
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
12.2
776
6031
M03BX02
ATC
tizanidine; oral
1.3
12.1
1938
17064
A01AB04
ATC
amphotericin B; local oral
2.0
12.1
132
677
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
12.0
731
5643
R06AX26
ATC
fexofenadine; oral
1.8
11.9
167
929
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
11.9
770
5998
WZC30
NOMESCO Finland
Teaching
1.4
11.7
522
3823
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.6
11.6
67
263
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
11.6
233
1436
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.6
11.5
66
258
R06AX22
ATC
ebastine; oral
1.5
11.5
414
2912
DPA30
NOMESCO Finland
Sphenotomy
4.2
11.5
30
72
ZY010, ,
SPAT
2.8
11.5
56
202
M79.6
ICD-10 Finland
Pain in limb
1.3
11.4
1398
11874
UJF32
NOMESCO Finland
Coloscopy
1.3
11.4
793
6238
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.5
11.3
67
267
WX704
NOMESCO Finland
Intubation
1.6
11.3
264
1691
R03CC03
ATC
terbutaline; systemic
2.3
11.3
79
340
C01DA14
ATC
isosorbide mononitrate; oral
1.4
11.2
450
3233
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
11.2
419
2970
0192, ,
NOMESCO Finland
25.1
11.1
15
6
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
11.0
287
1886
348
Kela drug reimbursment
Roflumilast
9.2
11.0
22
24
Z51.88
ICD-10 Finland
Other specified medical care
2.4
10.9
75
320
N06AB04
ATC
citalopram; systemic
1.4
10.9
597
4524
J01DA09
ATC
[U] cefadroxil
1.3
10.9
771
6080
R29
ICPC
Respiratory symptom/complaint other
1.7
10.7
219
1356
J01MA02
ATC
ciprofloxacin; systemic
1.3
10.7
1176
9836
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
10.6
1073
8882
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.3
10.6
76
331
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
10.5
1085
8998
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
10.2
154
877
SPAT1236
SPAT
Informing family of child’s disability
2.4
10.2
69
293
Z2221
NOMESCO Finland
Medical doctor
1.3
10.1
814
6526
J02AC01
ATC
fluconazole; systemic
1.3
10.1
1128
9440
Z71.8
ICD-10 Finland
Other specified counselling
1.3
10.1
1090
9086
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.0
9.9
42
140
UDM02
NOMESCO Finland
Sinoscopy
2.4
9.9
67
284
R49.01
ICD-10 Finland
Functional dysphonia
2.1
9.9
89
425
C03DA01
ATC
spironolactone; oral
1.5
9.9
367
2594
R06AX13
ATC
loratadine; oral
1.5
9.9
358
2519
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
9.9
404
2911
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.8
534
4038
R03AC19
ATC
olodaterol
5.1
9.8
20
39
R03DX09
ATC
mepolizumab; parenteral
20.0
9.8
14
7
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
2.9
9.7
45
158
ZYC01
NOMESCO Finland
Remote contact by phone
1.6
9.7
199
1235
N06AX11
ATC
mirtazapine; oral
1.3
9.7
1037
8626
M35.7
ICD-10 Finland
Hypermobility syndrome
2.9
9.7
44
153
Z3226
NOMESCO Finland
Physiotherapist
1.4
9.7
549
4180
R51.80
ICD-10 Finland
Headache
1.4
9.6
475
3534
A07AA02
ATC
nystatin; oral
1.7
9.5
159
934
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.6
9.5
55
217
EMB30
NOMESCO Finland
Adenotomy
2.0
9.5
104
535
R06.5
ICD-10 Finland
Mouth breathing
1.5
9.5
271
1818
J34.2
ICD-10 Finland
Deviated nasal septum
1.8
9.4
147
846
A02BA02
ATC
ranitidine; systemic
1.4
9.4
529
4020
81
HP
Angiography of the heart and coronary arteries
1.7
9.4
171
1028
E66.01
ICD-10 Finland
Obesity due to excess calories
1.5
9.4
280
1895
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.1
9.4
88
428
N06AX16
ATC
venlafaxine; oral
1.4
9.3
406
2956
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
4.7
9.3
21
45
N02BF01
ATC
gabapentin; oral
1.5
9.2
307
2127
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
3.3
9.1
34
105
TGC00
NOMESCO Finland
Bronchial lavation
2.2
9.1
76
353
XG466
NOMESCO Finland
Sleep oxymetry
2.0
9.1
91
454
R053, ,
ICD-10 Finland
1.9
9.0
110
587
J30.0
ICD-10 Finland
Vasomotor rhinitis
2.1
9.0
77
362
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.1
8.9
81
389
R05CB01
ATC
acetylcysteine; inhalant, oral
2.8
8.9
44
160
ZYC04, ,
SPAT
3.2
8.9
34
107
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
2.7
8.9
46
172
61
HP
Catheterization and pressure measurement of the left side of the heart
2.5
8.9
52
207
-, ,
ICD-10 Finland
2.3
8.8
66
293
OAB93, ,
SPAT
1.6
8.8
181
1124
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
4.7
8.8
20
43
J01FA01
ATC
erythromycin; systemic
1.4
8.8
377
2739
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
8.7
260
1760
GX1C5
NOMESCO Finland
PEF monitoring for assessment of efficacy of asthma management
50.1
8.7
10
*
G44.2
ICD-10 Finland
Tension-type headache
1.4
8.6
393
2883
R04
ICPC
Breathing problem other
1.8
8.6
123
690
J01FF01
ATC
clindamycin; systemic
1.3
8.6
773
6274
J21.99
ICD-10 Finland
Acute bronchiolitis, unspecified
4.4
8.6
21
48
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.3
8.5
30
90
C09CA01
ATC
losartan; oral
1.3
8.4
752
6098
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
8.4
90
460
90494, ,
NOMESCO Finland
90.2
8.4
9
*
M02AA07
ATC
piroxicam; topical
1.3
8.4
1023
8619
N06AX12
ATC
bupropion; oral
1.6
8.3
199
1282
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
8.3
799
6542
N06AB10
ATC
escitalopram; oral
1.3
8.2
596
4701
R01AD59
ATC
mometasone, combinations; nasal
1.6
8.2
188
1201
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.8
8.2
110
607
J01DC02
ATC
cefuroxime; systemic
1.7
8.2
146
875
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
4.5
8.1
19
42
R09
ICPC
Sinus symptom/complaint
1.5
8.1
238
1608
3028
Kela drug reimbursment
Mepolizumab
17.2
8.1
12
7
297, ,
Kela drug reimbursment
17.2
8.1
12
7
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
8.0
577
4542
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
7.9
327
2358
J01DA08
ATC
[U] cefaclor
1.4
7.9
327
2359
A03
ICPC
Fever
1.3
7.9
554
4346
M48.0
ICD-10 Finland
Spinal stenosis
1.4
7.9
339
2463
N03AX16
ATC
[U] pregabalin
1.3
7.9
642
5142
WX723
NOMESCO Finland
CPAP therapy
1.7
7.8
124
719
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
1.9
7.8
101
551
J01DA06
ATC
[U] cefuroxime
1.4
7.8
387
2881
GX1K5
NOMESCO Finland
Diffusion capacity
3.5
7.8
26
75
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
7.8
395
2952
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.7
375
2781
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
7.7
237
1615
XF402
NOMESCO Finland
ECG with work load test
1.4
7.7
292
2075
Z50.1
ICD-10 Finland
Other physical therapy
1.6
7.7
153
945
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.2
7.6
58
260
GX2D5
NOMESCO Finland
Sleep oximetry
3.4
7.6
26
76
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
3.2
7.6
29
91
ZXA00
NOMESCO Finland
Right side
1.3
7.6
752
6168
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.6
523
4091
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.9
7.6
90
478
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
7.5
480
3719
OAB47, ,
SPAT
1.7
7.5
137
828
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
7.4
745
6122
5906, ,
NOMESCO Finland
80.2
7.4
8
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
7.4
528
4152
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
7.3
613
4925
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.3
7.3
493
3847
I50.1
ICD-10 Finland
Left ventricular failure
1.7
7.3
136
826
ZXA05
NOMESCO Finland
Left side
1.3
7.3
691
5639
P01AB01
ATC
metronidazole; oral, rectal
1.2
7.2
1179
10215
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
7.2
171
1102
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
7.2
558
4436
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
2.9
7.1
31
106
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
2.8
7.1
33
117
R07.1
ICD-10 Finland
Chest pain on breathing
2.3
7.1
51
224
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.8
7.1
95
525
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.8
7.1
97
540
E0000UV, ,
ATC
1.2
7.1
1161
10064
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
7.0
308
2245
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
7.0
572
4578
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
7.0
687
5626
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
6.9
791
6591
DM1QA, ,
SPAT
1.7
6.9
117
692
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
6.9
365
2744
J01MA12
ATC
levofloxacin; systemic
1.3
6.9
511
4036
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
6.9
331
2450
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
13.8
6.9
11
8
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.5
6.9
180
1187
J35.2
ICD-10 Finland
Hypertrophy of adenoids
2.0
6.8
73
374
D07AC01
ATC
betamethasone; topical
1.2
6.8
1001
8568
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
6.8
98
553
GD1AD
NOMESCO Finland
Thorax CT examination
1.5
6.8
182
1207
R83
ICPC
Respiratory infection other
1.3
6.8
761
6330
R28
ICPC
Limited function/disability (R)
2.4
6.8
45
191
GX1B5
NOMESCO Finland
PEF monitoring for diagnosis of asthma
40.1
6.8
8
*
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.3
6.7
50
223
C10AX09
ATC
ezetimibe; oral
1.3
6.7
476
3738
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
6.7
268
1924
R49.08
ICD-10 Finland
Other specified dysphonia
2.1
6.6
62
303
I50.0
ICD-10 Finland
Congestive heart failure
1.5
6.6
203
1384
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
6.6
267
1919
DHB50
NOMESCO Finland
Turbinoplasty
2.0
6.6
64
317
R03DX07
ATC
roflumilast; oral
7.8
6.6
14
18
H50.52
ICD-10 Finland
Exophoria
2.5
6.6
38
151
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
6.6
1197
10464
R4110
NOMESCO Finland
Physiotherapy
1.2
6.6
820
6899
KMAK, ,
NOMESCO Finland
1.2
6.6
1533
13716
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.6
6.5
155
1000
T78.4
ICD-10 Finland
Allergy, unspecified
1.7
6.5
110
651
M79.7
ICD-10 Finland
Fibromyalgia
1.8
6.5
84
459
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.4
166
1092
J98.1
ICD-10 Finland
Pulmonary collapse
3.1
6.4
25
80
D07AB08
ATC
desonide; topical
1.4
6.4
238
1686
A10BJ06
ATC
semaglutide; parenteral
1.6
6.4
147
943
B37.0
ICD-10 Finland
Candidal stomatitis
2.7
6.3
32
119
J01
ICD-10 Finland
Acute sinusitis
1.6
6.3
147
945
49099
ICD-8 Finland
Bronchitis, unspecified
2.8
6.3
30
108
V07AB
ATC
Solvents and diluting agents, incl. irrigating solutions
11.0
6.3
11
10
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
6.2
657
5420
J92.9
ICD-10 Finland
Pleural plaque without asbestos
2.7
6.2
32
120
E66.8
ICD-10 Finland
Other obesity
1.6
6.2
148
956
M01AH02
ATC
rofecoxib; oral
1.4
6.2
325
2441
M54.5
ICD-10 Finland
Low back pain
1.2
6.2
1089
9477
M01AB05
ATC
diclofenac; systemic, rectal
1.2
6.2
2029
18663
L17
ICPC
Foot/toe symptom/complaint
1.2
6.2
933
8000
A03FA02
ATC
cisapride; oral, rectal
1.5
6.2
191
1306
N06AX26
ATC
vortioxetine; oral
1.5
6.2
209
1455
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.5
6.2
37
150
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
6.2
133
840
M01AX17
ATC
nimesulide; oral
1.3
6.1
641
5282
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.6
6.1
120
739
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
3.5
6.1
20
57
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.4
6.1
242
1733
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
2.9
6.1
27
93
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
6.1
610
4999
I45.1
ICD-10 Finland
Other and unspecified right bundle-branch block
3.2
6.1
23
72
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
6.1
218
1534
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
6.1
254
1838
395
Kela drug reimbursment
Dupilumab
12.5
6.1
10
8
RK310, ,
NOMESCO Finland
8.6
6.0
12
14
49300
ICD-8 Finland
Asthma, bronchiale
2.1
6.0
54
260
D11AH05
ATC
dupilumab; topical
10.0
6.0
11
11
XG431
NOMESCO Finland
Oscillometric spirometry with exercise provocation
6.7
6.0
14
21
J01X
ATC
OTHER ANTIBACTERIALS
3.6
6.0
19
53
XCK00
NOMESCO Finland
Perimetry
1.5
6.0
158
1044
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
761
1882
4.81
288.58
1.4
1.3
106.11
132.15
u/ml
1.15
724
1738
746
2186
4.00
222.44
1.8
1.4
—
—
—
0
0
160
193
8.60
123.19
1.1
1.4
0.84
1.37
u/ml
0.26
60
100
2335
17213
1.93
79.90
6.4
7.1
0.21
0.19
e9/l
7.75
2125
15033
2242
16684
1.84
70.22
6.3
6.8
0.59
0.58
e9/l
0.11
1995
14319
2245
16717
1.84
70.13
6.3
6.8
0.04
0.04
e9/l
4.36
1999
14343
2253
17099
1.79
62.84
6.4
6.9
2.00
1.95
e9/l
0.50
2059
15044
2361
18734
1.69
50.58
8.6
10.2
4.23
4.07
e9/l
2.80
2105
16209
1121
7828
1.61
36.30
4.5
4.0
1.02
1.40
kg/l
0.80
669
5231
396
2049
2.04
35.37
7.0
6.9
24.71
24.49
mmol/l
0.51
382
1958
622
3830
1.75
32.12
7.5
8.5
1.27
0.92
mmol/l
1.49
527
3136
150
3740
0.38
32.00
4.1
4.9
33.92
32.64
%
0.68
103
2497
623
3861
1.73
31.38
7.7
8.6
5.18
5.10
kpa
1.16
601
3714
623
3861
1.73
31.38
7.7
8.6
11.38
12.43
kpa
6.23
601
3713
1919
15556
1.47
29.18
6.4
6.9
56.80
56.79
%
0.01
1878
14912
1951
15883
1.47
28.92
6.6
7.1
28.15
28.31
%
0.27
1893
15093
627
3975
1.69
28.86
2.0
1.9
—
—
—
0
0
559
3459
1.72
28.08
7.8
9.0
95.19
95.64
%
0.94
535
3340
987
7029
1.55
28.00
2.0
2.1
1.01
1.30
mg/l
2.88
781
5470
2710
23649
1.51
27.62
4.8
4.4
11.56
11.98
mm/h
0.88
2599
22151
234
1097
2.21
26.89
2.6
2.7
—
—
—
0
0
523
3218
1.72
26.72
7.8
9.3
124.56
121.66
g/l
2.43
510
3142
2986
26794
1.54
24.94
25.1
20.4
332.05
332.40
g/l
1.34
2968
26638
1238
9490
1.45
23.67
3.4
3.4
1139.90
1429.91
ng/l
1.84
1076
8199
137
537
2.61
23.49
1.1
1.1
1.08
1.44
u/ml
0.22
67
280
204
964
2.18
22.97
1.3
1.3
—
—
—
0
0
119
448
2.71
22.11
1.1
1.1
1.41
1.51
g/l
2.08
111
404
623
4222
1.57
21.34
2.0
1.8
—
—
—
0
0
184
878
2.15
20.22
5.0
4.0
3.88
3.89
mmol/l
0.10
184
871
2941
26705
1.45
19.43
21.5
19.8
13.68
13.60
%
2.61
2914
26336
360
2175
1.72
19.38
9.5
11.0
92.86
94.12
%
3.00
360
2165
1758
14705
1.36
18.88
10.8
12.0
0.00
0.00
e9/l
0.38
1423
12011
2024
17361
1.36
18.21
4.4
3.9
4.02
3.79
estimate
0.02
338
3737
2031
17455
1.35
17.91
4.5
3.9
0.03
0.01
estimate
0.65
315
3523
1998
17147
1.35
17.69
4.4
3.9
0.00
0.00
estimate
0.38
333
3662
1564
12967
1.35
17.25
4.4
3.8
0.04
0.07
estimate
0.40
278
2991
110
452
2.47
17.17
1.0
1.1
0.72
4.23
u/ml
5.24
40
202
341
2113
1.67
16.66
9.7
11.2
0.65
0.65
%
0.09
341
2098
1767
14990
1.33
16.41
8.0
7.4
1.20
1.21
mmol/l
7.38
1686
13938
97
405
2.43
14.68
1.1
1.1
0.69
1.35
u/ml
0.58
34
184
763
5780
1.40
14.31
1.4
1.3
34.19
32.65
iu/ml
0.12
240
1759
387
2565
1.57
14.31
3.6
3.3
171.46
199.57
ng/l
0.65
368
2344
103
449
2.33
14.17
1.0
1.0
0.24
0.92
u/ml
1.26
33
152
167
879
1.94
14.10
1.2
1.1
3.62
4.27
0.28
25
101
382
2537
1.56
13.99
3.0
2.8
65.89
66.06
ml/min/173m2
0.03
167
1076
710
5334
1.41
13.94
1.3
1.3
9.14
10.69
u/ml
0.30
291
2108
136
673
2.06
13.67
1.7
1.3
—
—
—
0
0
136
673
2.06
13.67
1.7
1.3
—
—
—
0
0
71
266
2.70
13.45
1.1
1.1
6.31
9.66
iu/ml
0.51
15
77
77
302
2.58
13.32
3.8
4.5
—
—
—
0
0
282
1786
1.62
12.61
3.3
3.8
0.62
0.62
%
0.08
282
1775
102
467
2.21
12.54
1.1
1.1
2.25
3.30
0.32
11
66
85
360
2.39
12.52
1.1
1.0
1.48
1.85
u/ml
0.19
30
149
228
1373
1.70
12.39
1.8
1.9
41.57
39.41
u/l
0.82
193
1230
206
1209
1.74
12.28
1.3
1.2
0.28
0.92
u/ml
1.29
34
89
1930
16973
1.28
12.18
6.0
6.8
11.89
11.95
umol/l
0.06
1839
16201
1690
14629
1.28
12.08
4.9
5.4
35.74
35.66
g/l
0.24
1597
13774
282
1806
1.61
12.05
3.3
3.8
1.38
1.22
%
1.39
282
1795
82
348
2.38
12.04
1.1
1.0
1.33
3.51
u/ml
1.37
24
134
47
149
3.18
12.02
1.1
1.1
—
—
—
0
0
1411
11957
1.29
11.89
4.0
3.8
46.80
101.77
ng/l
0.76
964
8407
799
6272
1.35
11.73
4.1
3.9
467.11
448.84
ng/l
0.05
625
4865
2696
24813
1.30
11.46
4.7
4.3
14.82
14.78
pmol/l
0.38
2528
22793
1384
11799
1.27
10.83
3.6
3.5
—
2.05
—
0
5
1147
9564
1.28
10.71
4.7
4.0
0.00
0.00
estimate
1.54
315
3399
3311
31488
1.41
10.70
18.4
16.0
23.03
24.53
mg/l
1.89
2855
25842
151
847
1.81
10.54
1.2
1.1
—
—
—
0
0
720
5646
1.34
10.52
2.0
1.9
—
—
—
0
0
379
2672
1.46
10.38
3.0
3.2
10.15
10.50
g/l
0.74
361
2469
309
2094
1.52
10.29
2.2
2.0
1.40
1.34
g/l
0.13
296
1925
149
841
1.80
10.20
1.2
1.1
—
—
—
0
0
2648
24454
1.27
10.14
8.0
8.3
78.33
81.32
u/l
3.28
2551
23261
54
1282
0.41
10.05
1.4
1.9
—
—
—
0
0
127
686
1.88
10.01
1.4
1.5
—
—
—
0
0
114
596
1.94
9.91
1.1
1.1
9.88
22.29
au/ml
1.70
33
142
491
3667
1.39
9.74
4.2
5.0
2.27
1.76
mmol/l
2.44
430
3153
285
1921
1.52
9.74
10.5
11.7
16.26
16.01
%
0.80
274
1852
841
6809
1.30
9.69
1.6
1.6
2.28
2.35
g/l
0.41
556
4171
434
3185
1.41
9.54
3.9
4.6
4.54
4.66
kpa
0.57
425
3096
1873
16696
1.24
9.48
7.8
8.0
1.21
1.21
mmol/l
1.75
1674
14493
1208
10260
1.26
9.42
2.7
2.7
52.64
67.64
u/l
1.26
1143
9539
48
1162
0.41
9.38
1.4
1.8
—
—
—
0
0
497
3750
1.37
9.25
4.3
4.9
5.93
5.81
kpa
1.60
488
3650
421
3092
1.41
9.21
8.0
9.1
1.28
1.37
mmol/l
1.32
412
3035
940
7819
1.27
8.61
1.4
1.4
1.03
1.75
u/ml
2.88
277
2051
769
6241
1.29
8.58
1.7
1.6
—
—
—
0
0
1277
11065
1.23
8.01
3.7
3.4
32.87
35.20
u/l
0.33
1219
10465
69
326
2.14
7.98
1.0
1.0
0.39
0.13
u/ml
0.36
21
92
899
7496
1.26
7.98
2.8
2.8
5.29
6.07
e6/l
1.15
814
6849
140
837
1.70
7.91
1.7
2.1
11.33
11.59
mg/l
0.15
134
779
280
1967
1.46
7.82
10.1
11.2
24.82
24.25
mmol/l
2.17
275
1934
1087
9332
1.23
7.31
3.5
3.4
0.50
0.43
e6/l
0.26
817
6908
355
2641
1.38
7.18
2.7
2.4
5.40
7.19
ug/l
1.85
324
2354
232
1612
1.47
6.89
1.4
1.4
—
—
—
0
0
27
87
3.12
6.84
1.1
1.1
0.18
0.26
u/ml
0.99
27
87
764
6361
1.25
6.74
2.6
3.0
2.45
2.45
mmol/l
0.41
684
5721
1738
15722
1.19
6.58
3.4
3.2
106.58
121.47
ug/l
2.99
1639
14704
76
401
1.91
6.56
1.3
1.1
—
—
—
0
0
3058
29170
1.25
6.56
5.7
5.3
1.89
1.92
mu/l
0.62
2911
27072
25
79
3.18
6.55
1.0
1.0
19.06
38.19
iu/ml
1.58
25
79
1279
11259
1.20
6.52
2.8
3.5
2.35
2.36
mmol/l
1.16
1178
10310
294
2156
1.39
6.50
3.2
4.1
128.47
128.99
g/l
0.15
288
2093
164
1081
1.54
6.30
2.5
3.6
182.01
190.16
%
0.64
156
1044
129
804
1.62
6.29
1.4
1.5
—
—
—
0
0
1232
10836
1.20
6.28
3.6
3.5
98.21
79.96
e6/l
0.19
953
8319
2201
20398
1.19
6.13
3.3
3.0
—
—
—
0
0
416
3250
1.31
6.08
2.1
2.2
359.48
379.12
nmol/l
1.24
397
3013
28
99
2.84
6.08
1.1
1.2
—
—
—
0
0
15
25
6.01
5.98
1.5
2.0
41.40
50.28
umol/l
0.41
15
25
277
2043
1.38
5.93
3.5
3.4
4.53
4.54
pmol/l
0.07
252
1841
111
678
1.65
5.88
6.2
7.9
11.59
11.41
mmol/l
0.22
98
604
696
5816
1.24
5.87
3.1
3.0
1.33
1.03
e6/l
1.34
404
3113
111
679
1.65
5.85
6.2
7.9
105.09
105.25
mmol/l
0.16
98
605
130
831
1.58
5.74
2.4
2.3
137.05
129.97
g/l
2.29
101
674
625
5174
1.25
5.73
2.3
2.8
29.79
29.79
s
0.00
605
5045
956
8275
1.21
5.68
3.1
2.9
342.67
340.23
umol/l
0.31
872
7352
3301
31879
1.28
5.68
21.3
18.9
139.63
139.68
mmol/l
0.48
3267
31244
2087
19325
1.18
5.64
5.9
5.4
6.70
6.67
mmol/l
0.19
1991
18314
215
1537
1.42
5.54
3.3
3.5
25.35
25.26
mmol/l
0.14
210
1480
34
140
2.44
5.52
2.9
4.2
—
—
—
0
0
80
459
1.76
5.36
1.3
1.3
—
—
—
0
0
3302
31944
1.26
5.22
21.5
19.1
3.98
3.97
mmol/l
0.58
3263
31249
145
973
1.51
5.19
1.4
1.7
—
—
—
0
0
111
702
1.60
5.17
1.4
1.2
33.58
47.38
u/ml
—
6
80
471
3821
1.26
5.13
3.4
3.2
6.72
7.93
umol/l
0.77
416
3346
37
164
2.27
5.12
1.4
1.2
—
—
—
0
0
1057
9320
1.18
5.02
3.2
3.0
0.06
0.04
0.10
18
227
1374
12389
1.17
4.96
4.2
4.1
71.32
99.96
e6/l
0.77
979
8745
31
132
2.36
4.72
1.1
1.2
—
—
—
0
0
139
945
1.49
4.70
1.4
1.7
—
—
—
0
0
184
1320
1.41
4.69
2.3
1.8
5.13
7.03
iu/ml
0.61
51
317
1265
11377
1.17
4.65
3.5
3.6
7.47
7.55
mmol/l
0.27
1122
9703
1156
10335
1.17
4.57
3.5
3.5
45.20
48.61
mg/l
0.22
774
6673
26
104
2.51
4.53
2.2
2.9
5.10
4.88
kpa
0.57
26
104
26
104
2.51
4.53
2.2
2.9
9.73
10.20
kpa
0.37
26
104
1117
9967
1.17
4.51
2.3
2.2
185.96
221.57
u/l
0.64
1051
9467
2258
21258
1.15
4.31
5.1
4.7
3955.22
1547.02
e6/l
0.48
32
310
51
274
1.87
4.30
1.2
1.3
—
213.33
—
0
9
51
274
1.87
4.30
1.2
1.3
157.50
163.79
titre
0.02
12
58
1614
14854
1.15
4.23
16.6
15.2
1.27
1.26
inr
0.19
1330
12475
14
403
0.34
4.22
1.1
1.4
—
—
—
0
0
14
402
0.35
4.20
1.1
1.4
—
—
—
0
0
1170
10525
1.16
4.20
4.1
4.2
9.19
8.56
mg/mmol
0.16
754
6656
14
400
0.35
4.16
1.1
1.4
—
—
—
0
0
104
686
1.53
4.11
1.4
1.4
—
—
—
0
0
101
665
1.53
4.03
1.4
1.4
—
—
—
0
0
223
1706
1.33
3.86
1.5
1.5
—
—
—
0
0
102
681
1.51
3.83
2.3
2.3
79.53
105.33
ug/min
0.39
68
419
114
781
1.47
3.78
1.3
1.2
—
7.24
—
0
8
654
5664
1.19
3.73
3.6
4.2
0.82
0.82
mmol/l
0.23
623
5361
13
34
3.83
3.68
2.0
1.3
—
—
—
0
0
17
416
0.41
3.63
1.1
1.4
—
—
—
0
0
88
577
1.54
3.61
1.2
1.2
25.98
36.19
u/l
0.58
81
499
17
414
0.41
3.59
1.1
1.4
—
—
—
0
0
86
562
1.54
3.59
1.2
1.2
533.00
337.55
titre
—
5
49
77
491
1.58
3.58
1.4
1.3
6.72
5.04
u/ml
0.28
36
238
158
1162
1.37
3.56
1.7
1.6
—
—
—
0
0
75
478
1.58
3.50
1.4
1.6
—
—
—
0
0
158
1166
1.37
3.49
2.7
4.1
3.37
3.46
g/l
0.37
151
1119
18
422
0.42
3.48
1.2
1.4
—
—
—
0
0
18
70
2.58
3.37
2.2
2.6
989.72
40.98
ug/l
0.46
18
70
933
8375
1.15
3.34
4.7
4.6
90.97
88.83
%
1.81
910
8210
183
1392
1.33
3.33
5.1
5.6
0.89
0.88
%
0.13
171
1308
452
3826
1.20
3.32
2.0
1.8
1.53
1.47
%
1.10
403
3369
52
306
1.71
3.32
1.4
1.4
—
—
—
0
0
375
3123
1.22
3.26
2.4
2.5
38.47
54.94
u/l
0.50
330
2628
107
749
1.44
3.23
5.5
6.8
203.29
512.98
iu/ml
1.01
14
114
750
6656
1.16
3.13
1.7
1.7
75420281.69
31801473.36
pmol/l
0.83
655
5569
44
252
1.75
3.11
1.2
1.1
18.93
16.23
u/ml
0.21
18
92
21
92
2.29
3.09
1.2
1.0
—
—
—
0
0
30
152
1.98
3.08
1.2
1.1
—
—
—
0
0
30
153
1.97
3.03
1.1
1.1
—
—
—
0
0
76
509
1.50
2.90
1.4
1.3
7.07
3.89
u/ml
0.40
30
194
194
1520
1.29
2.89
5.0
5.3
1.84
1.60
%
2.28
182
1432
119
1606
0.73
2.87
1.8
2.2
0.00
0.50
estimate
0.51
39
509
59
375
1.58
2.85
1.0
1.1
—
—
—
0
0
122
896
1.37
2.84
1.4
1.3
7.39
6.70
u/ml
—
9
92
46
275
1.68
2.82
1.5
1.5
—
—
—
0
0
5
173
0.29
2.82
1.0
1.8
—
—
—
0
0
5
173
0.29
2.82
1.0
1.8
—
—
—
0
0
5
173
0.29
2.82
1.0
1.8
—
—
—
0
0
5
173
0.29
2.82
1.0
1.8
—
—
—
0
0
91
638
1.44
2.77
1.9
1.7
—
—
—
0
0
17
365
0.46
2.69
2.4
2.2
29.44
21.90
mg/l
—
9
133
53
335
1.59
2.64
3.5
3.6
13.37
13.42
index
0.01
35
204
414
3555
1.18
2.63
9.8
6.9
—
—
—
0
0
71
480
1.49
2.62
1.5
1.7
—
—
—
0
0
125
943
1.34
2.49
1.4
1.2
57.16
44.69
u/ml
—
5
46
130
989
1.32
2.45
1.4
1.4
287.29
279.70
ug/g
0.16
70
578
22
109
2.02
2.45
1.3
1.4
84.36
84.77
%
0.02
11
62
22
109
2.02
2.45
1.2
1.2
86.82
86.75
%
0.00
11
61
13
51
2.55
2.43
1.1
1.3
—
—
—
0
0
0
64
0.00
2.42
0.0
1.7
—
14.02
—
0
17
0
66
0.00
2.40
0.0
2.0
—
—
—
0
0
26
138
1.89
2.40
1.0
1.0
—
—
—
0
0
78
550
1.43
2.35
1.3
1.5
—
—
—
0
0
445
3882
1.16
2.34
2.1
2.2
—
—
—
0
0
118
893
1.33
2.32
1.4
1.3
3.72
8.30
u/ml
1.20
12
148
38
229
1.66
2.32
2.4
2.2
617.43
617.14
ml
0.00
28
154
43
268
1.61
2.31
1.1
1.1
—
—
—
0
0
79
561
1.42
2.30
2.0
1.9
4.95
5.01
mmol/24h
0.06
74
488
411
3574
1.17
2.26
1.9
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
141
1100
1.29
2.24
3.8
5.4
0.33
0.34
iu/ml
0.30
90
603
0
59
0.00
2.24
0.0
2.1
—
—
—
0
0
60
408
1.48
2.20
1.5
1.3
41.13
70.68
u/ml
—
6
22
189
1533
1.24
2.19
1.5
1.5
22.95
26.37
iu/l
0.85
156
1245
321
2750
1.18
2.13
2.5
2.9
66.85
66.29
g/l
0.64
302
2539
50
330
1.52
2.13
1.5
1.3
1.44
1.45
nmol/l
0.03
44
301
15
68
2.21
2.10
1.1
1.2
0.81
115.24
mg/l
—
9
49
42
268
1.57
2.08
1.1
1.1
—
—
—
0
0
47
308
1.53
2.07
1.2
1.2
—
—
—
0
0
5
10
5.00
2.07
1.2
1.0
—
—
—
0
0
2971
28966
1.12
2.06
6.7
6.2
39.43
39.13
mmol/mol
1.13
2855
27172
136
1070
1.28
2.05
1.5
1.6
0.17
7.01
iu/ml
0.58
40
197
8
194
0.41
2.03
1.0
1.3
—
—
—
0
0
43
278
1.55
2.02
1.1
1.1
—
—
—
0
0
22
390
0.56
2.01
1.0
1.4
283.50
278.65
mosm/kgh2o
0.48
16
302
40
255
1.57
2.00
1.2
1.2
—
—
—
0
0
487
4336
1.14
1.95
2.3
2.5
167.16
132.69
ug/g
0.33
398
3497
40
258
1.55
1.91
2.0
1.9
—
—
—
0
0
117
913
1.29
1.91
2.0
2.0
2.78
9.61
iu/l
0.60
54
392
70
506
1.39
1.90
1.2
1.1
—
—
—
0
0
631
5723
1.12
1.88
2.7
2.7
12.63
13.03
umol/l
0.79
591
5360
1625
15445
1.09
1.88
2.9
2.9
—
—
estimate
—
0
0
20
107
1.87
1.85
3.4
2.8
0.57
0.62
mmol/l
1.02
20
107
1394
13172
1.09
1.83
2.0
1.9
1.44
1.35
mmol/l
1.89
1196
11160
523
4699
1.13
1.83
6.5
7.1
1.07
1.07
mmol/l
0.06
502
4384
40
261
1.54
1.83
1.1
1.1
—
—
—
0
0
9
199
0.45
1.83
1.0
1.3
—
—
—
0
0
36
230
1.57
1.80
1.1
1.2
—
—
—
0
0
32
199
1.61
1.79
2.1
2.7
36.20
40.11
%
0.64
22
108
8
29
2.76
1.79
1.1
1.3
—
—
—
0
0
36
231
1.56
1.78
1.1
1.2
—
—
—
0
0
295
3391
0.86
1.78
2.0
1.9
3.36
3.46
ratio
0.73
225
2581
266
2286
1.17
1.75
1.2
1.2
68.68
144.60
u/ml
5.48
102
812
168
1384
1.22
1.74
1.8
1.7
0.28
0.31
mg/l
0.26
97
652
217
2549
0.84
1.71
7.7
5.1
5.11
5.12
kpa
0.11
209
2451
3383
33325
1.14
1.65
22.8
20.4
76.20
76.82
umol/l
0.53
3350
32921
17
303
0.56
1.63
1.6
1.4
—
—
—
0
0
5
130
0.38
1.62
1.0
1.9
—
—
—
0
0
584
5327
1.11
1.59
2.7
2.7
2.38
2.32
g/l
1.52
541
4952
84
645
1.31
1.59
1.4
1.7
—
—
—
0
0
31
198
1.57
1.59
1.1
1.1
0.59
6.10
nmol/l
—
10
36
55
396
1.39
1.57
1.1
1.2
—
—
—
0
0
119
957
1.25
1.57
1.5
1.5
—
—
—
0
0
55
399
1.38
1.52
2.0
1.7
90.34
89.75
%
0.35
55
394
17
93
1.83
1.51
4.2
6.5
4.84
5.18
kpa
0.44
17
93
5
129
0.39
1.48
1.0
1.9
—
—
—
0
0
5
129
0.39
1.48
1.0
1.9
—
—
—
0
0
57
420
1.36
1.44
3.1
2.7
8.43
9.29
umol/l
0.11
44
299
1478
14108
1.08
1.44
2.1
2.1
91.71
95.99
pmol/l
3.45
818
7500
112
907
1.24
1.42
3.2
3.4
3.08
2.18
index
0.81
60
486
1556
14889
1.08
1.41
2.7
2.5
76.25
76.63
nmol/l
0.20
1445
13588
3025
29673
1.09
1.41
5.2
5.0
5.92
5.91
mmol/l
0.17
2860
27334
77
982
0.78
1.38
1.2
1.3
—
—
—
0
0
15
82
1.83
1.35
1.5
1.6
8.74
8.70
ug/l
0.01
15
82
295
2616
1.14
1.32
4.3
4.5
93.49
88.45
ng/l
0.43
262
2286
214
1860
1.16
1.28
1.1
1.1
—
—
—
0
0
19
305
0.62
1.28
1.9
2.9
—
—
—
0
0
10
48
2.08
1.27
6.6
14.5
7.95
5.54
mmol/l
—
10
48
116
958
1.22
1.25
1.7
1.8
39.95
40.92
nmol/l
0.21
116
932
122
1014
1.21
1.24
1.4
1.5
8.08
9.66
u/l
0.79
96
765
134
1124
1.20
1.24
2.2
2.5
10.48
10.40
g/l
0.06
124
1009
21
131
1.60
1.23
1.7
2.1
165.57
173.04
%
0.15
21
124
580
5370
1.09
1.20
3.3
3.2
2.80
2.49
e6/l
0.29
284
2665
27
180
1.50
1.20
1.7
1.2
149.67
133.74
nmol/l
0.98
27
180
270
2399
1.13
1.20
1.6
1.7
—
—
—
0
0
195
2234
0.87
1.20
8.2
5.1
2.18
1.63
mmol/l
1.49
150
1646
53
400
1.33
1.20
1.6
1.3
7.90
7.16
mmol/l
0.87
42
356
43
314
1.37
1.19
5.3
5.6
205.39
64.87
u/ml
0.44
16
102
42
306
1.38
1.18
1.8
2.8
—
—
—
0
0
796
7478
1.08
1.17
5.0
4.5
20.61
22.00
%
2.07
388
3653
8
155
0.51
1.13
1.0
1.4
—
70.52
—
0
23
429
3929
1.10
1.13
4.4
4.7
252.60
244.87
u/l
0.32
409
3744
10
51
1.96
1.11
5.8
8.5
10.49
10.65
%
—
10
51
100
828
1.21
1.09
1.3
1.4
—
—
—
0
0
247
2199
1.13
1.08
2.3
2.4
18.01
19.63
au/ml
0.12
16
227
934
8856
1.07
1.07
2.5
2.4
2.88
2.79
mg/l
0.46
835
7711
102
850
1.20
1.05
2.4
2.4
0.00
0.00
g/l
-0.00
96
804
90
741
1.22
1.04
1.4
1.2
1.47
2.18
u/ml
—
7
50
978
9300
1.07
1.03
3.7
3.3
0.02
0.13
estimate
0.62
287
2871
109
918
1.19
1.01
2.3
2.3
0.00
0.00
g/l
-0.00
96
805
223
1984
1.13
1.00
1.9
2.0
—
—
—
0
0
66
528
1.25
1.00
1.2
1.2
—
—
—
0
0
12
68
1.77
1.00
1.3
1.1
—
—
—
0
0
259
2332
1.12
0.96
2.2
2.1
—
—
—
0
0
114
969
1.18
0.96
3.9
3.6
7.81
3.09
ratio
0.42
62
569
361
3309
1.10
0.96
3.1
3.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
186
0.59
0.96
1.2
1.2
—
—
—
0
0
39
293
1.33
0.95
1.3
1.6
—
—
—
0
0
39
293
1.33
0.95
1.3
1.6
—
—
—
0
0
39
293
1.33
0.95
1.3
1.6
—
—
—
0
0
144
1249
1.16
0.95
10.1
5.9
8.42
8.71
kpa
1.23
138
1223
113
963
1.18
0.93
2.3
2.3
0.11
0.03
g/l
0.48
102
862
137
1188
1.16
0.91
2.6
2.4
409.47
675.22
ug/l
0.70
131
1129
37
278
1.33
0.91
1.5
1.5
29.26
30.92
%
0.10
23
171
135
1171
1.16
0.90
1.6
1.6
15.13
17.18
u/ml
0.21
25
265
298
2716
1.10
0.90
2.3
2.6
0.38
0.46
e6/l
0.18
280
2604
73
600
1.22
0.89
4.8
4.5
1026.80
933.12
u/ml
—
5
51
228
2525
0.90
0.88
1.7
1.7
3.33
3.43
mmol/l
0.83
162
1715
26
358
0.72
0.88
1.4
1.5
—
—
—
0
0
18
265
0.68
0.88
1.3
1.1
—
46.18
—
0
11
27
194
1.39
0.87
1.4
1.6
—
—
—
0
0
526
4925
1.08
0.87
2.8
2.8
21.76
22.72
%
0.90
492
4601
175
1551
1.13
0.87
1.7
1.8
1.47
1.52
g/l
0.31
155
1354
99
842
1.18
0.85
1.1
1.1
6.64
5.90
eliau/ml
—
9
96
97
825
1.18
0.84
1.6
1.8
—
—
—
0
0
330
3037
1.09
0.83
2.4
3.0
71.78
68.89
e9/l
0.70
239
2223
36
274
1.32
0.83
1.6
1.4
1.25
1.21
promille
0.04
28
218
29
214
1.36
0.82
1.2
1.2
0.53
0.58
ratio
0.38
16
120
145
1277
1.14
0.81
2.2
2.2
8290.48
6314.28
u/l
0.24
48
508
43
338
1.27
0.79
1.1
1.1
—
—
—
0
0
3338
33048
1.08
0.79
12.7
12.0
26.21
26.07
u/l
0.19
3271
32120
92
785
1.18
0.78
1.5
1.5
273.40
246.06
u/ml
0.34
55
460
26
190
1.37
0.78
1.9
1.8
—
—
—
0
0
521
5524
0.93
0.78
3.0
3.2
0.66
0.77
ug/l
3.34
338
3595
45
561
0.80
0.77
2.5
3.7
0.81
1.49
%
1.48
40
505
14
210
0.66
0.77
1.2
1.2
—
—
—
0
0
6
34
1.76
0.76
1.2
1.1
138.67
95.06
titre
—
6
34
6
34
1.76
0.76
2.3
1.2
6.28
5.90
mmol/l
—
6
34
155
1379
1.13
0.75
2.1
2.0
4.06
2.30
ug/l
0.35
142
1227
8
134
0.60
0.73
1.0
1.2
—
—
—
0
0
5
25
2.00
0.72
7.0
10.3
—
—
—
0
0
7
39
1.79
0.72
2.0
4.0
105.29
98.62
g/l
—
7
39
39
308
1.27
0.71
1.7
2.7
10.90
14.33
%
1.86
39
299
7
41
1.71
0.69
1.1
1.1
—
—
—
0
0
222
2027
1.10
0.69
1.3
1.3
30.45
53.91
au/ml
1.26
11
131
287
2652
1.09
0.69
2.5
2.3
12.03
12.68
nmol/l
0.65
261
2393
84
721
1.17
0.69
1.6
1.6
144.87
135.75
au/ml
0.29
23
233
3470
34435
1.08
0.68
27.6
24.1
90.84
90.81
fl
0.19
3447
34077
3470
34438
1.08
0.67
28.3
24.8
40.65
40.45
%
0.53
3444
34061
3470
34439
1.08
0.67
27.6
24.2
4.52
4.49
e12/l
2.99
3411
33627
5
28
1.79
0.66
1.0
1.0
2.04
6.48
u/ml
—
5
28
794
8264
0.95
0.66
2.5
2.5
—
—
—
0
0
10
62
1.61
0.65
1.1
1.0
—
—
—
0
0
5
29
1.72
0.63
1.0
1.1
0.00
0.24
u/ml
—
5
15
3470
34447
1.08
0.63
27.7
24.2
7.03
6.76
e9/l
7.84
3417
33632
3470
34447
1.08
0.63
28.0
24.4
135.63
134.73
g/l
3.20
3444
34092
3468
34429
1.08
0.62
27.7
24.2
258.02
251.61
e9/l
7.00
3422
33719
557
5299
1.06
0.61
1.7
1.8
1292.99
1165.94
nmol/l
2.62
444
4063
0
21
0.00
0.60
0.0
4.7
—
—
—
0
0
123
1099
1.12
0.60
4.0
3.8
134.77
56.79
mg/l
0.35
97
940
950
9172
1.05
0.59
1.7
1.7
19.95
20.22
nmol/l
0.24
846
7826
123
1100
1.12
0.59
4.0
3.8
42.75
106.57
mg/l
0.71
97
943
512
4866
1.06
0.59
1.5
1.5
—
—
—
0
0
25
192
1.30
0.58
1.2
1.1
1901.22
1430.04
miu/ml
0.83
25
192
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
141
1557
0.90
0.58
1.6
1.6
1046.07
979.59
mu/l
0.32
122
1332
8
53
1.51
0.58
7.5
5.8
2.41
2.19
mg/l
—
8
40
121
1083
1.12
0.58
1.4
1.3
243.01
210.43
miu/ml
0.42
52
484
73
838
0.87
0.56
1.5
1.6
66.68
58.39
ug/l
0.70
58
704
32
256
1.25
0.56
3.4
2.6
23.31
29.50
mg/l
0.45
21
173
47
393
1.20
0.55
3.0
4.7
7.13
7.09
mmol/l
0.02
33
331
2979
29473
1.05
0.55
16.0
15.4
82.92
81.86
ml/min/173m2
1.91
2761
27125
6
38
1.58
0.54
1.0
1.0
162.50
160.71
g/l
—
6
38
33
267
1.24
0.53
1.5
1.6
—
—
—
0
0
11
74
1.49
0.53
1.3
1.2
—
—
—
0
0
55
469
1.17
0.53
4.9
7.7
11.01
11.95
mg/l
0.87
50
442
59
684
0.86
0.53
4.2
3.4
27.67
26.79
mg/l
0.07
40
458
67
769
0.87
0.53
1.5
1.5
1.13
1.17
ratio
0.14
37
458
67
769
0.87
0.53
1.5
1.5
0.90
0.94
ratio
0.54
37
456
89
788
1.13
0.52
1.7
1.6
9911.22
13172.17
e6/l
0.51
64
552
9
133
0.68
0.51
1.7
2.2
58.22
66.13
ug/l
—
9
128
67
767
0.87
0.51
1.5
1.5
1.24
1.12
ratio
0.55
37
454
346
3269
1.06
0.50
7.4
8.7
9.84
9.52
mmol/l
0.35
334
3144
19
144
1.32
0.50
4.3
3.9
1.53
1.22
%
0.29
19
144
16
118
1.36
0.50
1.0
1.2
—
—
—
0
0
15
200
0.75
0.48
1.9
1.5
—
—
—
0
0
93
832
1.12
0.47
1.4
1.4
—
84.42
—
0
12
24
190
1.26
0.47
1.5
3.1
30.79
27.66
%
0.35
24
181
25
200
1.25
0.46
7.4
7.5
5.84
107.73
ug/l
0.66
15
131
67
759
0.88
0.46
1.5
1.5
—
—
—
0
0
25
309
0.81
0.46
1.2
1.1
—
40.52
—
0
21
70
787
0.89
0.43
2.7
3.0
31.85
35.69
umol/l
0.87
60
716
142
1308
1.09
0.43
2.2
2.4
3.78
3.71
g/l
0.27
132
1202
20
157
1.27
0.43
1.9
2.0
217.13
147.77
umol/l
—
8
91
142
1309
1.09
0.42
2.2
2.4
7.41
7.41
g/l
0.01
132
1202
142
1309
1.09
0.42
2.2
2.4
4.31
4.20
g/l
0.45
131
1203
42
359
1.17
0.42
3.0
3.1
11.74
10.68
mmol/l
1.04
42
354
28
230
1.22
0.42
1.2
1.3
10.39
11.78
u/l
0.41
23
211
51
443
1.15
0.42
1.3
1.3
359.15
332.62
pmol/l
0.18
41
376
3110
30853
1.04
0.41
6.1
5.6
2.65
2.70
mmol/l
1.67
2970
28811
46
398
1.16
0.40
1.3
1.7
—
—
—
0
0
279
2644
1.06
0.40
4.4
4.1
1.23
1.23
mmol/l
0.13
237
2286
5
35
1.43
0.39
1.0
1.1
1.54
1.84
umol/24h
—
5
35
113
1036
1.09
0.39
1.5
1.5
—
—
—
0
0
11
80
1.37
0.38
8.8
7.4
—
2707.00
—
0
9
5
36
1.39
0.38
6.0
6.7
—
—
—
0
0
5
36
1.39
0.38
1.2
1.0
—
—
—
0
0
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
20
161
1.24
0.36
1.2
1.2
8.30
9.19
mm/h
0.31
20
161
55
618
0.89
0.36
2.9
3.4
0.80
0.83
nmol/l
0.16
43
495
5
80
0.62
0.35
1.0
1.5
—
—
—
0
0
2905
28810
1.03
0.35
4.3
4.2
1.29
1.28
mmol/l
0.60
2757
26646
54
479
1.13
0.35
4.2
5.6
349.80
370.62
umol/l
0.52
45
428
26
217
1.20
0.35
1.0
1.0
335.95
327.71
ng/l
0.05
21
143
132
1227
1.08
0.35
2.2
2.5
3.08
2.93
g/l
1.01
122
1121
6
44
1.36
0.34
4.2
5.1
—
—
—
0
0
26
218
1.19
0.34
1.0
1.0
824.52
702.66
ng/l
0.68
21
140
85
777
1.10
0.33
1.5
1.7
—
—
—
0
0
22
182
1.21
0.32
1.0
1.2
—
—
—
0
0
26
219
1.19
0.32
1.0
1.0
46.62
44.60
ng/l
0.08
19
143
56
502
1.12
0.32
1.6
1.5
0.29
0.37
nmol/l
0.60
46
382
128
1195
1.07
0.31
1.6
1.7
279.13
301.25
mu/l
0.38
114
1089
32
276
1.16
0.31
1.3
1.1
49.71
42.75
mg/l
0.12
27
226
114
1062
1.07
0.30
1.4
1.3
—
—
—
0
0
45
400
1.13
0.30
1.5
1.5
—
—
—
0
0
14
174
0.80
0.29
1.3
1.5
—
—
—
0
0
13
163
0.80
0.29
1.4
1.4
30.56
33.34
nmol/l
0.16
13
141
24
204
1.18
0.28
2.8
2.3
1.63
1.80
umol/l
0.52
24
190
20
167
1.20
0.28
1.3
1.7
9.59
6.84
nmol/l
0.11
15
132
178
1690
1.05
0.27
3.5
3.2
1.02
1.02
ratio
0.45
161
1535
53
584
0.91
0.27
1.2
1.1
185.00
1000.28
iu/ml
—
8
135
121
1136
1.07
0.27
2.4
2.4
0.84
1.01
g/l
0.16
104
972
16
131
1.22
0.27
1.3
1.1
156.71
220.99
iu/ml
0.89
16
131
20
168
1.19
0.27
20.9
30.3
147.42
127.54
ug/l
0.41
12
142
33
290
1.14
0.26
1.0
1.2
111.06
106.89
pmol/l
0.22
33
290
21
246
0.85
0.26
1.5
1.2
—
—
—
0
0
32
281
1.14
0.26
1.1
1.1
—
—
—
0
0
217
2079
1.05
0.24
1.9
1.7
—
—
—
0
0
2166
21456
1.02
0.24
3.5
3.4
46.35
47.13
u/l
0.14
2057
20199
16
190
0.84
0.23
1.7
1.5
0.73
7.15
u/l
7.31
11
152
40
360
1.11
0.23
1.4
1.7
—
—
—
0
0
17
143
1.19
0.23
1.1
1.1
—
367.35
—
0
40
17
200
0.85
0.23
1.6
1.5
76.00
85.32
umol/l
0.98
17
200
87
814
1.07
0.22
1.2
2.0
8.40
31.58
e6/l
1.42
67
608
73
679
1.08
0.22
1.5
1.6
—
—
—
0
0
12
146
0.82
0.22
3.3
3.8
2.83
1.49
ug/l
0.54
12
139
125
1185
1.06
0.22
3.3
3.5
6777.58
2903.01
u/ml
0.28
108
1027
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
32
356
0.90
0.21
1.4
1.6
47.18
60.03
%
0.90
17
222
325
3343
0.97
0.21
3.4
4.2
86.02
21.18
ug/l
0.90
277
2717
8
105
0.76
0.21
1.1
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
22
192
1.15
0.20
1.0
1.1
0.90
1.17
u/l
—
5
86
955
9401
1.02
0.20
5.3
5.5
3.92
3.41
ug/l
0.14
873
8483
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
9
115
0.78
0.20
1.9
1.5
0.52
0.49
e9/l
—
9
115
117
1112
1.05
0.20
1.3
1.8
8.14
4.41
mg/l
1.14
85
812
6
53
1.13
0.18
4.2
2.6
16.13
15.21
ml/dl
—
6
47
76
806
0.94
0.18
3.4
3.1
1.50
1.52
mmol/l
0.06
76
781
111
1057
1.05
0.18
1.3
1.3
—
—
—
0
0
12
100
1.20
0.18
1.0
1.4
—
—
—
0
0
25
223
1.12
0.18
1.4
1.5
—
—
—
0
0
3060
30461
1.02
0.17
5.2
5.0
4.58
4.61
mmol/l
0.87
2937
28575
39
359
1.09
0.16
1.3
1.6
284.29
342.61
mu/l
1.14
34
285
87
826
1.05
0.16
1.3
2.0
2671.91
1259.52
e6/l
0.38
68
650
11
92
1.20
0.16
1.4
1.2
97.33
434.38
ug/l
—
5
39
23
206
1.12
0.15
1.5
1.5
—
—
—
0
0
9
78
1.15
0.15
2.4
2.1
16.47
17.85
umol/l
—
9
78
165
1703
0.97
0.15
2.8
3.6
23.68
73.57
u/ml
5.59
159
1642
24
217
1.11
0.14
1.8
1.5
31.00
21.23
u/ml
—
6
39
13
112
1.16
0.14
1.0
1.3
—
—
—
0
0
22
198
1.11
0.14
1.5
1.6
—
—
—
0
0
8
96
0.83
0.13
1.1
1.1
—
—
—
0
0
8
96
0.83
0.13
1.1
1.1
—
—
—
0
0
8
99
0.81
0.13
1.1
1.1
—
—
—
0
0
33
305
1.08
0.13
1.3
1.3
15322.04
90401.70
e6/l
1.47
24
208
9
110
0.82
0.13
3.3
1.4
49.63
391.79
nmol/24h
—
9
110
47
442
1.06
0.12
1.1
1.1
1.13
3.68
eliau/ml
1.98
22
186
97
1006
0.96
0.12
1.5
1.5
—
—
—
0
0
86
828
1.04
0.10
1.2
1.8
3.63
3.68
mmol/l
0.18
81
785
81
779
1.04
0.10
3.4
4.9
64.06
62.06
%
0.33
81
774
34
361
0.94
0.10
3.4
2.3
1.20
1.20
mmol/l
0.18
34
355
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
22
203
1.08
0.09
1.3
2.2
—
—
—
0
0
22
203
1.08
0.09
1.3
2.2
—
—
—
0
0
45
429
1.05
0.08
1.2
1.3
—
—
—
0
0
35
369
0.95
0.08
3.3
2.3
4.13
4.05
mmol/l
0.53
35
363
35
369
0.95
0.08
3.3
2.3
105.23
105.38
mmol/l
0.06
35
363
5
63
0.79
0.08
1.2
1.6
—
0.66
—
0
5
24
224
1.07
0.08
1.8
1.9
—
—
—
0
0
16
147
1.09
0.07
1.1
1.3
170.44
159.80
mmol/24h
0.10
16
147
8
90
0.89
0.06
1.3
1.4
—
—
—
0
0
41
393
1.04
0.06
1.5
1.4
2016.39
1892.15
e6/l
0.08
33
273
73
709
1.03
0.06
2.0
1.8
—
—
—
0
0
42
436
0.96
0.06
1.1
1.3
—
—
—
0
0
33
315
1.05
0.06
1.1
1.2
57.29
73.90
u/l
0.78
28
281
18
192
0.94
0.05
1.2
1.4
174.23
218.27
pmol/l
0.40
18
192
26
273
0.95
0.05
1.2
1.2
—
—
—
0
0
19
201
0.94
0.04
2.8
2.1
7.58
8.34
mmol/l
0.49
19
201
44
453
0.97
0.04
1.3
1.1
—
13.91
—
0
22
63
642
0.98
0.03
1.4
1.6
52.30
59.33
ug/l
0.93
63
642
3032
30265
1.00
0.03
5.1
4.9
1.46
1.46
mmol/l
0.21
2900
28224
47
459
1.02
0.03
1.6
1.3
0.64
4.43
nmol/l
0.49
47
446
12
128
0.94
0.02
1.2
1.1
—
—
—
0
0
114
1127
1.01
0.02
1.1
1.1
1.57
1.54
g/l
0.45
114
1127
93
919
1.01
0.02
1.6
1.7
—
—
—
0
0
35
358
0.98
0.02
3.0
3.3
18.83
20.57
nmol/l
0.33
35
343
333
3314
1.00
0.01
2.5
2.4
0.22
0.21
g/l
1.02
306
3109
79
798
0.99
0.01
1.3
1.3
—
—
—
0
0
35
343
1.02
0.01
1.5
1.4
40090.91
72070.65
e6/l
0.48
22
191
69
695
0.99
0.00
2.0
2.0
0.86
0.82
nmol/l
0.11
58
599
16
156
1.02
0.00
1.1
1.1
—
—
—
0
0
28
285
0.98
0.00
1.4
3.1
535.77
550.55
e6/l
0.05
22
215
40
405
0.99
0.00
1.5
1.3
0.18
0.23
nmol/l
0.47
30
321
107
1064
1.00
0.00
1.1
1.1
0.61
0.61
ratio
0.01
11
140
11
105
1.05
0.00
1.8
2.1
2140.00
3382.45
e6/l
—
6
56
14
138
1.01
0.00
1.0
1.9
—
25310.78
—
0
23
25
247
1.01
0.00
1.1
1.1
—
—
—
0
0
67
668
1.00
0.00
3.4
3.2
8.03
7.46
mmol/l
0.62
67
645
0
6
0.00
-0.00
0.0
1.0
—
185.67
—
0
6
5
50
1.00
-0.00
1.2
1.1
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.1
110.30
72.64
ug/l
—
5
39
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.0
—
—
—
0
0
8
87
0.92
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
30.00
—
0
7
5
51
0.98
-0.00
1.6
1.5
131.24
84.10
ng/l
—
5
36
5
58
0.86
-0.00
1.0
1.4
—
—
—
0
0
8
79
1.01
-0.00
6.3
5.5
10.13
8.54
%
—
8
79
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.92
-0.00
1.4
1.2
61.80
69.78
ug/l
—
5
54
8
85
0.94
-0.00
1.8
1.6
0.34
0.39
ug/l
—
8
55
5
49
1.02
-0.00
1.2
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ASTHMA_NONALLERG – Non-allergic asthma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).